Resumo Um macho de Pteronura brasiliensis (Carnivora: Mustelidae) foi encontrado morto às margens do Rio Negro, no Pantanal do estado de Mato Grosso do Sul, município de Aquidauana. Dois carrapatos encontrados aderidos à sua pele foram identificados, morfologicamente, como uma ninfa de segundo ínstar de Ornithodoros rostratus (Argasidae) e um macho de Amblyomma sculptum (Ixodidae). Para complementar a identificação morfológica, esses espécimes de carrapatos foram submetidos à extração de DNA e testados por meio de ensaios de PCR, para confirmar a identidade molecular dos espécimes. Além disso, os extraídos dos carrapatos foram testados e revelaram-se negativos nos ensaios de PCR para todos os patógenos testados. Também foram examinados 30 lotes, compostos por 174 indivíduos de O. rostratus, depositados na Coleção Acari do Instituto Butantan, e encontramos material de quatro estados brasileiros, incluindo-se um lote contendo 2 machos e 2 fêmeas de Aquidauana, estado de Mato Grosso do Sul (MS), coletado do solo. Este foi, portanto, o primeiro registro de O. rostratus parasitando P. brasiliensis e o primeiro registro de localidade (Aquidauana). Da mesma forma, A. sculptum é comumente encontrado no Pantanal e relatado aqui, pela segunda vez, parasitando a ariranha, hospedeiro pouco estudado em relação a ectoparasitas.

Abstract A male of Pteronura brasiliensis (Carnivora: Mustelidae) was found dead on the banks of the Rio Negro, in the Pantanal wetlands of Mato Grosso do Sul state, Aquidauana municipality. Two ticks found attached to its skin were morphologically identified as a second-instar nymph of Ornithodoros rostratus (Argasidae) and a male of Amblyomma sculptum (Ixodidae). In order to complement the morphological identification, these tick specimens were subjected to DNA extraction, and tested using PCR assays to confirm the molecular identity the specimens. Also, the tick DNA samples were tested and were negative in the PCR assays for all the pathogens tested. We also examined 30 batches, consisting of 174 individuals of O. rostratus deposited in the Acari Collection of the Butantan Institute, and we found material from four Brazilian states, including one batch containing 2 males and 2 females from Aquidauana, of Mato Grosso do Sul state, collected from the soil. This was therefore the first record of O. rostratus parasitizing P. brasiliensis and the first locality record (Aquidauana). Likewise, A. sculptum is commonly found in the Pantanal and is reported here for the second time parasitizing the giant otter, which is a host little studied regarding the ectoparasites.

Resumo Fundamento São restritos os dados sobre o manejo e o prognóstico dos pacientes com infarto agudo do miocárdio com supradesnivelamento do segmento ST (IAMCSST) com acometimento multiarterial no Brasil, o que mostra a necessidade de investigar as estratégias de revascularização disponíveis. Objetivo Avaliar os desfechos relacionados à revascularização completa em comparação com o tratamento da artéria culpada em pacientes multiarteriais com IAMCSST. Métodos Foi realizada um estudo de coorte prospectiva em dois centros de hemodinâmica do Sul do Brasil, com seguimento de 1 ano após a intervenção índice. O desfecho primário foi composto de óbito cardiovascular, reinfarto ou angina recorrente e secundários acidente vascular encefálico, parada cardiorrespiratória não fatal, sangramento maior ou necessidade de reintervenção. A probabilidade de ocorrência de desfechos foi comparada entre os grupos através de regressão logística binária. Considerou-se como estatisticamente significativo o valor de probabilidade < 0,05. Resultados Participaram 85 pacientes, com média de idade de 62±12 anos, sendo 61 (71,8%) do sexo masculino. Cinquenta e oito (68,2%) pacientes receberam a estratégia de revascularização completa e 27 (31,8%), a de revascularização incompleta. A chance de ocorrência tanto do desfecho primário quanto do secundário foi significativamente maior entre os indivíduos tratados com revascularização incompleta quando comparados com os tratados com estratégia completa [razão de chances (OR) 5,1, intervalo de confiança de 95% (IC95%) 1,6-16,1 vs. OR 5,2, IC95% 1,2-22,9, respectivamente], assim como os óbitos cardiovasculares (OR 6,4, IC95% 1,2-35,3). Conclusão Dados deste registro regional, de dois centros do Sul do Brasil, demonstram que a estratégia de revascularização completa esteve associada à redução significativa dos desfechos primário e secundário no seguimento de 1 ano quando comparada à estratégia de revascularização incompleta. (Arq Bras Cardiol. 2020; 115(2):229-237)

Abstract Background Data on the management and prognosis of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease are limited in Brazil, showing that the available revascularization strategies should be investigated Objective To assess the outcomes of complete revascularization versus treatment of the culprit artery only in patients with STEMI and multivessel disease. Methods A prospective cohort study was conducted at two medical centers in southern Brazil with a 1-year follow-up after the index procedure. The primary outcome was a composite of cardiac death, reinfarction, or recurrent angina, while the secondary outcome was stroke, nonfatal cardiac arrest, major bleeding, or need for reintervention. The probability of outcomes occurring was compared between the groups using binary logistic regression. A p-value < 0.05 was considered statistically significant. Results Eighty-five patients were included. Their mean age was 62±12 years, and 61 (71.8%) were male. Fifty-eight (68.2%) were treated with complete revascularization and 27 (31.8%) with incomplete revascularization. The chance of both the primary and secondary outcomes occurring was significantly greater among patients treated with incomplete revascularization when compared to those treated with complete revascularization (odds ratio [OR] 5.1, 95% confidence interval [CI] 1.6-16.1 vs. OR 5.2, 95% CI 1.2-22.9, respectively), as well as cardiac death (OR 6.4, 95% CI 1.2-35.3). Conclusion Registry data from two centers in southern Brazil demonstrate that the complete revascularization strategy is associated with a significant reduction in primary and secondary outcomes in a 1-year follow-up when compared to the incomplete revascularization strategy (Arq Bras Cardiol. 2020; 115(2):229-237)

ABSTRACT The objective of this study was to identify dietary patterns in an outpatient cohort of coronary heart disease (CHD) patients, to compare these patterns with dietary recommendations of the international cardiology guidelines, and verify associations with cardiovascular risk factors. Dietary intake was assessed through a food frequency questionnaire. Dietary patterns were identified by cluster analysis. The total energy intake, fiber, cholesterol, macro and micronutrients were calculated. Two dietary patterns were identified in 123 patients. Pattern I was characterized by a greater consumption of whole carbohydrates, beans, meats, vegetables, and fruits. Pattern II was rich in refined carbohydrates, fried foods, and sweets. Participants in pattern I had lower values of diastolic blood pressure (DBP) with 77.1 ± 9.9 mmHg (p= 0.002) and glycated hemoglobin (HbA1c) of 7.83 ± 1.76 % (p= 0.029) compared to pattern II with 84.1 ± 14.3 mmHg and 9.02 ± 2.29 %, respectively. Therefore, pattern I had a healthier nutritional composition, however, nutritional adequacy was still lacking. Despite this, participants in pattern I had significantly lower values of DBP and HbA1c, in addition to being associated with a better control of DBP.

RESUMEN El objetivo de este estudio fue identificar los modelos dietéticos de una cohorte de pacientes ambulatorios con enfermedad de las arterias coronarias (EAC) y compararlos con las recomendaciones dietéticas de las directrices internacionales de cardiología y verificar su asociación con el control de los factores de riesgo cardiovascular. La ingesta dietética se evaluó mediante un cuestionario de frecuencia de consumo. El modelo dietético fue identificado por análisis de conglomerados. Se calculó la ingesta energética total, fibras, colesterol, macro y micronutrientes. Se identificaron dos modelos dietéticos en 123 pacientes. El modelo I se caracterizó por un mayor consumo de carbohidratos enteros, frijoles, carnes, verduras y frutas. El modelo II era rico en carbohidratos refinados, alimentos fritos y dulces. Los participantes en el modelo I tuvieron valores más bajos de presión arterial diastólica (PAD) con 77.1 ± 9.9 mmHg (p= 0.002) y hemoglobina glucosilada (HbA1c) de 7.83 ± 1.76 % (p= 0.029) en comparación con el modelo II con 84.1 ± 14.3 mmHg y 9.02 ± 2.29%, respectivamente. Por lo tanto, el modelo I tenía una composición nutricional más saludable, sin embargo, todavía carece de adecuación nutricional. A pesar de esto, los participantes del modelo I tuvieron valores más bajos de PAD y HbA1c.

Abstract Introduction: bariatric surgery is a favorable option for the treatment of obesity, resulting in long-term weight loss. Objectives: to analyze whether feeding behavior, evaluated by caloric intake, dietary preferences and tolerance, can be considered as a determinant factor for weight loss in obese patients submitted to Roux-en-Y gastric bypass (RYGB). Methods: cross-sectional study of 105 patients with at least two years post-RYGB surgery with a preoperative body mass index (BMI) of ≥ 35 kg/m². Caloric intake was evaluated by 24-hour dietary recall and 3-day dietary intake record; dietary habits, by a qualitative dietary frequency questionnaire; and food tolerance, with a validated questionnaire. Multiple logistic regression was used for statistical analysis. Results: the majority of the 105 participants were female (84%). The mean age was 43.3 ± 11.4 years in the success group (n = 64) and 43.4 ± 10.7 years in the failure group (n = 41). Preoperative BMI was not associated with the outcome. Mean caloric intake did not show significant differences between groups: 24 hours recall, p = 0.27; 3-day record, p = 0.95. The frequency of weekly consumption of desserts was twice as high in the success group. Only two patients in the success group presented daily vomiting. Conclusion: the factors that determine the failure of weight loss have not yet been fully elucidated. Caloric intake was not a determining factor of failure, and insufficient weight loss was more prevalent in patients who ceased to lose weight earlier.

Resumen Introducción: la cirugía bariátrica es una opción favorable para el tratamiento de la obesidad, resultando a largo plazo en pérdida de peso. Objetivos: analizar si el comportamiento alimentario, evaluado por la ingesta calórica, las preferencias y las tolerancias alimentarias, puede ser considerado un factor determinante de los resultados de pérdida de peso en pacientes obesos sometidos a bypass gástrico en Y de Roux (BPGYR). Métodos: se realizó un estudio de cohorte retrospectivo con 105 pacientes sometidos a cirugía de BPGYR, con índice de masa corporal (IMC) preoperatorio ≥ 35 kg/m² y, como mínimo, dos años de postoperatorio. La ingesta calórica fue evaluada por el recordatorio alimentario de 24 horas y el registro alimentario de tres días. Para la evaluación de los hábitos alimentarios se empleó un cuestionario cualitativo de frecuencia alimentaria y para la tolerancia alimentaria, un cuestionario validado. Resultados: la mayoría de los participantes eran del sexo femenino (84%). La edad promedio fue de 43,30 ± 11,39 años en el grupo éxito y de 43,39 ± 10,73 años en el grupo sin éxito. El IMC preoperatorio no presentó influencia sobre el resultado final. El promedio de ingesta calórica no mostró diferencia significativa entre los grupos estudiados (R 24 h, p = 0,27; registro del diario alimentario, p = 0,95). La frecuencia del consumo semanal de dulces fue dos veces mayor en el grupo éxito. Apenas dos pacientes del grupo éxito presentaban vómitos diarios. Conclusión: los factores que determinan la falta de éxito en la pérdida de peso aún no están bien esclarecidos. La ingesta calórica no fue un factor determinante para no obtener éxito y la pérdida de peso insuficiente fue más prevalente en los pacientes que dejaron de perder peso más temprano.

Resumo Fundamento: A cirurgia de revascularização miocárdica (CRM) e a intervenção coronária percutânea (ICP) são estratégias amplamente utilizadas no manejo da doença arterial coronariana (DAC) estável. Objetivo: Avaliar o prognóstico de pacientes com DAC estável inicialmente tratada com terapia médica (TM), em comparação com os pacientes submetidos a procedimentos de revascularização. Métodos: Estudo prospectivo de coorte com 560 pacientes ambulatoriais de um hospital terciário com seguimento médio de 5 anos. Os pacientes foram classificados nos grupos TM (n = 288), ICP (n = 159) e CRM (n = 113) de acordo com sua estratégia inicial de tratamento. Os desfechos primários foram mortalidade global e eventos combinados de morte, síndrome coronária aguda e AVC. Resultados: Durante o seguimento, as taxas de mortalidade foram de 11,1% em TM, 11,9% em ICP e 15,9% em pacientes submetidos à CRM, sem diferença estatística (Hazard Ratio [HR] para ICP, 1,05; Intervalo de Confiança de 95% [IC95%], 0,59 a 1,84; e HR para CRM, 1,20; IC95%, 0,68 a 2,15). Os desfechos combinados ocorreram com maior frequência entre os pacientes inicialmente submetidos à ICP em relação à TM (HR 1,50, IC 95% 1,05 a 2,14) e não diferiram entre TM e CRM (HR 1,24, IC95% 0,84 a 1,83). Entre os pacientes com diabetes (n = 198), a ICP foi a única estratégia terapêutica preditiva de desfechos combinados (HR 2,14; IC 95%: 1,25 a 3,63). Conclusão: Neste estudo observacional de doença arterial coronariana estável, não houve diferença na mortalidade global entre as estratégias iniciais de terapia médico ou de cirurgia de revascularização. Os pacientes inicialmente tratados com ICP tiveram maior chance de desenvolver eventos cardiovasculares maiores combinados.

Abstract Background: Coronary artery bypass grafting surgery (CABG) and percutaneous coronary intervention (PCI) are widely-used strategies in the management of stable coronary artery disease (CAD). Objective: To evaluate the prognosis of patients with stable CAD initially treated by medical therapy (MT), compared to the patients who were submitted to revascularization procedures. Methods: We conducted a prospective cohort study of 560 patients from an outpatient clinic in a tertiary hospital, with a mean follow-up of 5 years. Patients were classified into MT (n = 288), PCI (n = 159) and CABG (n=113) groups according to their initial treatment strategy. Primary endpoints were overall mortality and combined events of death, acute coronary syndrome, and stroke. Results: During follow-up, death rates were 11.1% in MT, 11.9% in PCI and 15.9% in CABG patients, with no statistical difference (hazard ratio [HR] for PCI, 1.05; 95% confidence interval [95%CI], 0.59 to 1.84; and HR for CABG, 1.20; 95% CI: 0.68 to 2.15). Combined outcomes occurred more often among patients initially submitted to PCI compared to MT (HR 1.50, 95% CI 1.05 to 2.14), and did not differ between MT and CABG patients (HR 1.24, 95% CI 0.84 to 1.83). Among patients with diabetes (n=198), PCI was the only therapeutic strategy predictive of combined outcomes (HR 2.14; 95% CI 1.25 to 3.63). Conclusion: In this observational study of stable coronary artery disease, there was no difference in overall mortality between initial medical therapy or revascularization surgery strategies. Patients initially treated with PCI had greater chance to develop combined major cardiovascular events.

Introduction: Assessing severity and nutritional prognosis in critical patients has become increasingly important in recent years, since these parameters are related to morbidity/mortality and used to guide therapeutic options. Objective: Determine nutritional prognosis through the Phase Angle (PA) and Onodera's Prognostic Nutritional Index (OPNI) and its relationship with severity, hospitalization time and mortality of critically ill patients. Methods: Descriptive cross-sectional study, involving adult patients hospitalized in an Intensive Care Unit (ICU). Data were collected from the patients' medical records to calculate severity indicators (APACHE II, SOFA and SAPS 3) and determine the length of hospitalization and outcome. Bioimpedance was conducted to calculate the PA, using resistance and reactance data. Results: A total of 35 patients (26% men and 74% women), with mean age of 55.5 ± 16.7 years, were included. The mortality rate (17%) was similar to that expected by APACHE II and SOFA, but higher than that predicted by SAPS 3. The mean values for the PA (4.2 ± 1.0) and OPNI (38.7 ± 8.3) were lower than the reference values adopted. Individuals with PA < 5.1 exhibited significantly lower reactance and albumin and higher APACHE II and SOFA values, in addition to longer hospitalization time and higher mortality. The PA was inversely correlated with all the severity indicators under study (APACHE II, SOFA and SAPS 3), and the length of hospitalization. By contrast, there was no correlation between OPNI and these parameters, or between PA and OPNI. Conclusion: The PA proved to be a good tool in assessing nutritional prognosis in critically ill patients. By contrast, more studies using the OPNI with this type of patients are needed.

Introducción: en los últimos años se ha valorado la evaluación de la gravedad y del pronóstico nutricional en pacientes críticos, por ser parámetros relacionados a la morbimortalidad y porteadores de conductas terapéuticas. Objetivo: verificar el pronóstico nutricional mediante el Ángulo de Fase (AF) y el Índice de Pronóstico Nutricional de Onodera (OPNI) y su relación con la gravedad, con el tiempo de internación y con la mortalidad de pacientes críticos. Métodos: estudio transversal descriptivo, incluyendo pacientes adultos, internados en Unidad de Terapia Intensiva (UTI). Fueron recabados datos en la historia clínica de los pacientes para cálculo de los indicadores de gravedad (APACHE II, SOFA y SAPS 3), y verificación del tiempo de internación y desenlace. Fue realizada la bioimpedancia para cálculo del AF, mediante datos de resistencia y reactancia. Resultados: se incluyeron 35 pacientes, con edad promedio de 55,5 ± 16,7 años, siendo 26% del sexo masculino y 74% del femenino. La tasa de mortalidad encontrada en el estudio (17%) fue semejante a aquella esperada por los indicadores de gravedad APACHE II y SOFA, pero superior a aquella esperada por el SAPS 3. Los valores promedios encontrados para el AF (4,2 ± 1,0) y el OPNI (38,7 ± 8,3) fueron inferiores a los valores de referencia adoptados. Aquellos con AF < 5,1 presentaron significativamente menores valores de reactancia y albumina, mayores valores del APACHE II y del SOFA, y tuvieron mayor tiempo de internación y mortalidad. El AF se correlacionó inversamente con todos los indicadores de gravedad, pero lo contrario fue observado con el OPNI, no habiendo correlación entre estos dos indicadores de pronóstico nutricional. Conclusión: el AF es una herramienta confiable para evaluación del pronóstico nutricional en pacientes críticos. Por el contrario, se necesitan más estudios utilizando el OPNI con este tipo de pacientes.

ABSTRACT Periodontal disease has been associated with elevations of blood cytokines involved in atherosclerosis in systemically healthy individuals, but little is known about this association in stable cardiovascular patients. The aim of this study was to assess the association between periodontal disease (exposure) and blood cytokine levels (outcomes) in a target population of patients with stable coronary artery disease (CAD). Material and Methods This cross-sectional study included 91 patients with stable CAD who had been under optimized cardiovascular care. Blood levels of IL-1β, IL-6, IL-8, IL-10, IFN-γ, and TNF-α were measured by Luminex technology. A full-mouth periodontal examination was conducted to record probing depth (PD) and clinical attachment (CA) loss. Multiple linear regression models, adjusting for gender, body mass index, oral hypoglycemic drugs, smoking, and occurre:nce of acute myocardial infarction were applied. Results CAD patients that experienced major events had higher concentrations of IFN-γ (median: 5.05 pg/mL vs. 3.01 pg/mL; p=0.01), IL-10 (median: 2.33 pg/mL vs. 1.01 pg/mL; p=0.03), and TNF-α (median: 9.17 pg/mL vs. 7.47 pg/mL; p=0.02). Higher numbers of teeth with at least 6 mm of CA loss (R2=0.07) and PD (R2=0.06) were significantly associated with higher IFN-γ log concentrations. Mean CA loss (R2=0.05) and PD (R2=0.06) were significantly related to IL-10 concentrations. Elevated concentrations of TNF-α were associated with higher mean CA loss (R2=0.07). Conclusion Periodontal disease is associated with increased systemic inflammation in stable cardiovascular patients. These findings provide additional evidence supporting the idea that periodontal disease can be a prognostic factor in cardiovascular patients.

Resumo Jaguatiricas possuem um papel fundamental em comunidades ecológicas como mesopredadores, afetando níveis tróficos inferiores e também outros mesopredadores. Esta espécie possui uma grande variabilidade em suas características ecológicas em toda a sua distribuição, no entanto, o conhecimento desta espécie possui lacunas em vários locais onde ela ocorre. Neste trabalho, nós apresentamos o primeiro estudo desta espécie no semiárido brasileiro da Caatinga. Ambientes áridos podem afetar negativamente as espécies carnívoras e, aliado a alterações antrópicas, esta espécie pode ser levada a extinção local se sua densidade populacional é baixa. Portanto, para verificar o nível populacional da jaguatirica em uma região protegida da Caatinga, instalamos armadilhas fotográficas, entre setembro de 2009 e janeiro de 2010. Com os dados obtidos, calculamos a densidade desta espécie através de métodos espacialmente explícitos (SECR). A densidade estimada da jaguatirica foi de 3.16 ± 0.46 indivíduos por 100 km2. Esta estimativa é muito baixa para esta espécie, o que pode ser um reflexo das condições áridas deste ambiente. Um estudo populacional de maior duração pode ajudar a responder se esta baixa densidade é o suficiente para a persistência desta espécie a longo prazo tanto neste, quanto em outros ambientes áridos onde ela ocorre.

Abstract Ocelots play a key role in ecological communities as mesopredators affecting the lower trophic level and other mesopredators. They show great variability in ecological traits across their distribution, but knowledge of this species is missing in several regions where it occurs. Here, we present the first study of ocelot in the Brazilian semiarid of Caatinga. Arid habitats might keep carnivore population density low and therefore vulnerable to environmental shocks and to human-induced changes, at risk of local extinction. To assess their population status, we used camera traps between September 2009 and January 2010. We estimated the density of ocelots using a spatially explicit capture-recapture method (SECR) to be 3.16 ± 0.46 individuals per 100 km2. This is a low-density estimate for ocelots, which might reflect the harsh conditions of the arid habitat. A longer population study of the ocelot can answer if this low population density is enough for a long-term persistence of this species in this and other arid environments.

Objective Lymph node metastases (LNM) are frequent in patients with papillary thyroid cancer (PTC). The risk of persistent disease (PD) and tumor recurrence (TR) is increased when factors for poor prognosis other than LNM exist, when LNM are numerous, large, detected by preoperative ultrasonography (US), or exhibit extranodal extension. This study evaluated the risk of PD and TR in patients with LNM not exhibiting these characteristics.Subjects and methods Eighty-six patients with 5 or fewer LNM detected during intraoperative inspection, but not by preoperative US, who had no other factors for poor prognosis [tumors > 4 cm, extensive extrathyroid invasion, vascular invasion, aggressive histological subtype, distant metastases, incomplete tumor resection], were studied. All patients underwent total thyroidectomy followed by radioiodine ablation. PD was defined as metastases on initial post-therapy whole-body scans (RxWBS) or detected by imaging methods up to 12 months after ablation. TR was defined as structural disease diagnosed more than one year after ablation in patients without PD.Results PD was diagnosed in 3/86 patients (3.5%). TR was observed in 2/83 patients (2.5%) after 62 months of follow-up. There was no case of death due to the disease. A correlation was observed between pre-ablation Tg and PD or TR [1/48 (2%) with Tg ≤ 2 ng/mL versus 2/22 (9%) with Tg > 2 ≤ 10 ng/mL versus 2/7 (28.5%) with Tg ≥ 10 ng/ml)]. It is noteworthy that 38 patients had up to 3 positive LN and pre-ablation Tg ≤ 2 ng/ml, and none of them had PD or TR.Conclusions The frequency of PD and TR was low in patients with PTC with 5 or fewer LNM and without other factors for poor prognosis. Low postoperative stimulated Tg was predictive of the absence of PD and TR in these patients.

RACIONAL: A literatura mostra que a derivação gastrojejunal em Y-de-Roux apresenta grande eficiência no controle do peso como também na resolução do diabete melito tipo 2, porém estudos após o bypass gástrico em Y-de-Roux tem mostrado piora do controle glicêmico em porcentagem considerável e os fatores associados não são completamente conhecidos. OBJETIVO: Estudar o perfil dos pacientes obesos, que apresentaram ausência de remissão do diabete e/ou perda insuficiente de peso, submetidos ao bypass gástrico em Y-de-Roux. MÉTODO: Estudo caso-controle, incluindo 32 pacientes submetidos à esta operação há pelo menos dois anos com resultados insatisfatórios relacionados à perda de peso ou ausência de remissão completa do diabete. Um grupo controle foi constituído por outros 32 pacientes submetidos à mesma operação e no mesmo serviço, pareados por idade e tempo de operação. Um questionário estruturado foi aplicado com e dados clínicos e laboratoriais colhidos e analisados. RESULTADOS: Dos casos e controles avaliados, o IMC médio foi de 38,9 kg/m² e 29,5 kg/m²; a perda do excesso de peso foi de 56,10% e 77,23%; o percentual de reganho de peso, do peso inicial perdido, foi de 20,22% e 7,67%. Os antecedentes familiares para diabete e hipertensão arterial mostraram relação significativa entre casos e controles, com razão de chances de 9,00 para diabete, 5,44 para hipertensão e intolerância alimentar mostrou relação significativa entre casos e controles. CONCLUSÃO: Intolerância alimentar persistente e antecedentes familiares para diabete e hipertensão mostraram-se associados à menor perda e reganho de peso, ou menor chance de remissão completa do diabete após o bypass gástrico.

BACKGROUND: The literature reports that gastrojejunal derivation with Roux-en-Y gastric bypass is highly efficient in controlling weight and resolving; but studies have shown worsened glycemic control in a considerable number of patients and associated factors that have not been fully elucidated. AIM: To analyze the profile of patients submitted to gastric bypass that did not achieve satisfactory weight loss or complete diabetes remission. METHODS: Case-control study of 32 patients submitted to gastric bypass with at least two years postoperative time, unsatisfactory results in terms of weight loss or absence of complete diabetes remission. The control group was composed of another 32 patients submitted to the same operation at the same facility, matched for age and postoperative time. A structured questionnaire was applied and clinical and laboratory data were analyzed. RESULTS: Among the cases and controls, BMI was 38.9 kg/m² and 29.5 kg/m2, excess weight loss was 56.1% and 77.2%, % excess weight regain of initial excess weight loss, was 20.2% and 7.7%, respectively. Family history of type 2 diabetes mellitus, hypertension and food intolerance showed a significant relationship between cases and controls. CONCLUSION: Food intolerance and family history of hypertension and diabetes were associated to lower loss and weight regain or less likelihood of complete diabetes remission after gastric bypass.

FUNDAMENTO: Já foi demonstrado o uso do NT-proBNP pré-operatório para prever resultado cardíaco adverso, embora estudos recentes tenham sugerido que a determinação do NT-proBNP pós-operatório possa fornecer um valor adicional em pacientes submetidos à cirurgia não cardíaca. OBJETIVO: Avaliar o valor prognóstico perioperatório do NT-proBNP em pacientes de intermediário e alto risco cardiovascular submetidos à cirurgia não cardíaca. MÉTODOS: Este estudo incluiu prospectivamente 145 pacientes com idade > 45 anos, com pelo menos um fator de risco do Índice de Risco Cardíaco Revisado e submetidos à cirurgia de médio ou alto risco não-cardíaca. Os níveis de NTproBNP foram medidos no pré e pós-operatório. Preditores cardíacos de curto prazo foram avaliados por modelos de regressão logística. RESULTADOS: Durante uma mediana de acompanhamento de 29 dias, 17 pacientes (11,7%) apresentaram eventos cardíacos adversos importantes (MACE - 14 infartos do miocárdio não fatais, 2 paradas cardíacas não-fatais e 3 mortes cardíacas). Os níveis ótimos de limiar discriminatório para o NT-proBNP pré e pós-operatório foram 917 e 2962 pg/ mL, respectivamente. O NT-proBNP pré e pós-operatório (OR = 4,7, IC 95%: 1,62-13,73, p = 0,005 e OR 4,5, IC 95%: 1,53-13,16, p = 0,006) foram associados de forma significativa com MACE (eventos cardíacos adversos maiores). O NTproBNP pré-operatório foi significativa e independentemente associado com eventos cardíacos adversos em análise de regressão multivariada (OR ajustado 4,2, IC 95%: 1,38-12,62, p = 0,011). CONCLUSÃO: O NT-proBNP é um importante marcador de curto prazo de eventos cardiovasculares perioperatórios em pacientes de alto risco. Os níveis pós-operatórios foram menos informativos do que os níveis pré-operatórios. Uma única medição de NT-proBNP pré-operatório deve ser considerada na avaliação de risco pré-operatório.

BACKGROUND: Preoperative NT-proBNP has been shown to predict adverse cardiac outcomes, although recent studies suggested that postoperative NT-proBNP determination could provide additional information in patients submitted to noncardiac surgery. OBJECTIVE: To evaluate the prognostic value of perioperative NT-proBNP in intermediate and high risk cardiovascular patients undergoing noncardiac surgery. METHODS: This study prospectively enrolled 145 patients aged >45 years, with at least one Revised Cardiac Risk Index risk factor and submitted to intermediate or high risk noncardiac surgery. NT-proBNP levels were measured pre- and postoperatively. Short-term cardiac outcome predictors were evaluated by logistic regression models. RESULTS: During a median follow-up of 29 days, 17 patients (11.7%) experienced major adverse cardiac events (MACE- 14 nonfatal myocardial infarctions, 2 nonfatal cardiac arrests and 3 cardiac deaths). The optimum discriminatory threshold levels for pre- and postoperative NT-proBNP were 917 and 2962 pg/mL, respectively. Pre- and postoperative NT-proBNP (OR 4.7; 95% CI 1.62-13.73; p=0.005 and OR 4.5; 95% CI 1.53-13.16; p=0.006) were significantly associated with MACE. Preoperative NT-proBNP was significantly and independently associated with adverse cardiac events in multivariate regression analysis (adjusted OR 4.2; 95% CI 1.38-12.62; p=0.011). CONCLUSION: NT-proBNP is a powerful short-term marker of perioperative cardiovascular events in high risk patients. Postoperative levels were less informative than preoperative levels. A single preoperative NT-proBNP measurement should be considered in the preoperative risk assessment.

RACIONAL: A derivação gastrojejunal em Y-de-Roux é considerada um dos tratamentos mais eficientes para a manutenção de peso a longo prazo; porém, está associada à falhas manifestadas por impossibilidade de manutenção ou reganho de peso e descontrole glicêmico. OBJETIVO: Estudar os possíveis fatores que influenciam na falha do controle de peso e ou remissão da DM2. MÉTODOS: Estudo do tipo caso-controle, com 159 pacientes submetidos ao bypass gástrico com dois anos ou mais de pós-operatório, sendo selecionados para casos 24 pacientes com perda ponderal insatisfatória e ou ausência de remissão da DM2 e para controle 24 pacientes com perda ponderal satisfatória e ou remissão do DM2, pareados por idade e tempo de pós-operatório. RESULTADOS: Dos 24 casos e 24 controles avaliados, o percentual de reganho de peso foi de 19,32% e 8,68% e o percentual de remissão da DM2 foi de 26,6% e 87,5% assim como o percentual de recorrência da DM2 foi de 6,6% e 0,0% para casos e controles. Observando o IMC máximo pré-operatório, os casos apresentaram em média 53,50±12,24 kg/m2 e controles 48,77±5,19 kg/m2 sendo que o IMC máximo anterior ao bypass gástrico foi estatisticamente significativo no que se refere à falha no controle de peso ou insucesso da operação. CONCLUSÃO: Pacientes com IMC máximo inicial elevado (≥ 50kg/m2) apresentaram maior índice de falha na perda ponderal. A intolerância alimentar e diferenças socioeconômicas são consideradas fatores de reganho de peso.

BACKGROUND: Roux-en-Y gastric by-pass is considered one of the most effective treatments for maintaining long-term weight loss. However, it is associated to failures manifested by the inability to maintain weight loss, weight gain or poor glycemic control. OBJETIVE: Study the possible factors that influence weight loss failure and/or DM2 remission. METHODS: Case-control study of 159 patients submitted to gastric by-pass two or more years postoperatively. Twenty-four individuals with unsatisfactory weight loss and/or DM2 remission were selected as cases and 24 with satisfactory weight loss and/or absence of DM2 remission as controls, matched for age and postoperative time. RESULTS: Of the 24 cases and controls evaluated, the percentage weight gain was 19.32% and 8.68%, percentage DM2 remission 26.6% and 87.5% and percentage DM2 recurrence 6.6% and 0.0%, respectively. Cases and controls exhibited mean maximum preoperative BMI of 53.50±12.24 kg/m2 and 48.77±5.19 kg/m2, respectively. These values were statistically significant in terms of poor weight management or failed surgery. CONCLUSION: Patients with elevated initial maximum BMI (≥ 50kg/m2) displayed higher weight loss failure rates. Food intolerance and socioeconomic differences are considered factors in weight gain.

This study investigates the use of wild animal hair of C. brachyurus, C. thous and L. pardalis as biomonitors of trace metal at Parque Nacional das Emas, Brazil. Results reveal a strong correlation between Cd and Pb as well as Cu and Zn, which suggests a single source of emission. Most metals showed a lower or equal concentration than those obtained in previous studies. The research shows that monitoring may be performed only with Zn, Pb, Cd, and Cr because of statistical similarity and of a non-natural occurrence of large amounts of the material under analysis.

A avaliação da secreção do hormônio de crescimento (GH) permanece importante na acromegalia e o nadir do GH (n-GH) no teste de tolerância oral à glicose (TTOG) é o padrão-ouro na demonstração da autonomia secretória deste hormônio. Considera-se supressão normal valores < 1 µg/L, mas, com os ensaios atuais, n-GH < 1 µg/L é encontrado em pacientes com acromegalia não-tratada; e em indivíduos normais este valor parece ser bem menor. O objetivo do estudo foi avaliar o n-GH no TTOG em indivíduos normais, usando três ensaios diferentes (GH ICMA Immulite, GH IRMA DSL e GH IFMA AutoDelfia). Duzentos voluntários aparentemente saudáveis (120 mulheres) com idade entre 18 e 70 anos e índice de massa corporal (IMC) > 18,5 e < 27 kg/m², que não usavam medicamentos e apresentavam hemograma, glicemia e dosagens séricas de albumina, creatinina, TSH, TGO, TGP e bilirrubinas normais, foram estudados. Amostras de soro foram obtidas antes e 30, 60, 90 e 120 minutos após administração oral de 75 g de glicose. O teste foi repetido após quatro semanas em 157 participantes, com o mesmo protocolo sendo usado em 79 pacientes e sobrecarga oral de 100 g de glicose nos outros 78. Os valores de corte do n-GH (percentil 97,5) foram maiores em mulheres que nos homens (GH-IFMA: 0,30 versus 0,11 µg/L; GH-ICMA: 0,60 versus 0,25 µg/L; GH-IRMA: 0,20 versus 0,10 µg/L, respectivamente). Nenhuma correlação foi observada entre n-GH e idade ou IMC. Uma diferença foi vista apenas quando foi comparado mulheres < 35 anos (n = 40) versus > 35 anos (n = 80), com valores maiores nas primeiras (valor de corte do n-GH neste subgrupo: GH-IFMA 0,40 versus 0,26 µg/L, GH-ICMA 0,74 versus 0,50 µg/L, GH-IRMA 0,25 versus 0,15 µg/L). Houve boa correlação entre os ensaios (r = 0,9-0,96), mas valores maiores foram sempre obtidos com o kit Immulite. A repetição do teste com 75 g de glicose oral mostrou variação no n-GH < 10,2% (GH-IFMA), < 13,4% (GH-ICMA) e < 11% (GH-IRMA) em 95% dos indivíduos. Esta variação foi similar quando o teste foi repetido com 100 g de glicose. Uma boa correlação foi observada entre o n-GH no primeiro e segundo testes (r = 0,83-0,92). Sugere-se os seguintes valores de referência para o n-GH: para homens, 0,14 µg/L para os kits GH IRMA DSL e GH IFMA Auto Delfia e 0,25 µg/L para o kit GH ICMA Immulite; para mulheres, 0,25 µg/L, 0,40 µg/L e 0,70 µg/L, respectivamente.

The evaluation of growth hormone (GH) secretion continues to be important in acromegaly and the nadir GH (n-GH) level in the oral glucose tolerance test (OGTT) is the gold standard for the demonstration of secretory autonomy of this hormone. n-GH levels < 1 µg/L are defined as normal suppression but, using current assays, n-GH < 1 µg/L is detected in patients with untreated acromegaly and this value seems to be much lower in normal subjects. The objective of the present study was to evaluate n-GH levels in the OGTT in normal subjects using three different assays (GH ICMA Immulite; GH IRMA DSL and GH IFMA AutoDelfia). Two-hundred apparently healthy subjects (120 women) ranging in age from 18 to 70 years and with a BMI > 18.5 and < 27 kg/m², who used no medications and presented normal glycemia, blood count, albumin, creatinine, TSH, SGOT, SGPT and bilirubin were studied. Serum samples were obtained before and 30,60,90 and 120 min after oral administration of 75 g glucose. The test was repeated after 4 weeks in 157 participants, with the same protocol being used in 79 and 78 receiving an overload of 100 g glucose. n-GH cut-off values (97.5th percentile) were higher in women than in men (GH-IFMA: 0.30 versus 0.11 µg/L; GH-ICMA: 0.60 versus 0.25 µg/L; GH-IRMA: 0.20 versus 0.10 µg/L, respectively). No correlation was observed between n-GH and age or BMI. A difference was only observed when comparing women < 35 years (n = 40) versus > 35 years (n = 80), with higher values in the former (n-GH cut-off in this subgroup: GH-IFMA 0.40 versus 0.26 µg/L, GH-ICMA 0.74 versus 0.50 µg/L, GH-IRMA 0.25 versus 0.15 µg/L). A good correlation was observed between the assays (r = 0.9-0.96), however, the highest values were always obtained with the Immulite assay. Test repetition with 75 g oral glucose showed a variation in n-GH < 10.2% (GH-IFMA), < 13.4% (GH-ICMA) and < 11% (GH-IRMA) in 95% of the subjects. This variation was similar when the test was repeated with 100 g glucose. A good correlation was observed between n-GH in the first and second test (r = 0.83-0.92). We suggest the following n-GH reference values: for men, 0.14 µg/L for the GH IRMA DSL and GH IFMA AutoDelfia kits and 0.25 µg/L for the GH ICMA Immulite kit; for women, 0.25 µg/L, 0.40 µg/L and 0.70 µg/L, respectively.